Lisata Therapeutics (LSTA)
1.02
-0.03 (2.86%)
Upcoming Events
Latest Headlines
Form ARS LISATA THERAPEUTICS, For: Dec 31
October 19, 2026 8:56 AM - SEC Filing
Form DEF 14A LISATA THERAPEUTICS, For: Nov 09
October 19, 2026 6:38 AM - SEC Filing
Form 3 LISATA THERAPEUTICS, For: Oct 13 Filed by: Farrow Jeffrey S
October 15, 2026 8:45 PM - SEC Filing
Form 8-K LISATA THERAPEUTICS, For: Oct 13
October 14, 2026 4:26 PM - SEC Filing
Lisata Therapeutics adds Jeffrey Farrow to its board of directors
October 14, 2026 4:05 PM - StreetInsider
Lisata Therapeutics Appoints Jeff Farrow to Board of Directors
October 14, 2026 4:05 PM - StreetInsider
Lisata gets new patent for certepetide in pancreatic cancer treatment
October 8, 2026 8:04 AM - StreetInsider
Lisata Therapeutics Announces New Method of Use Patent Granted for Certepetide in the Treatment of Pancreatic Cancer and Other Solid Tumors
October 8, 2026 8:00 AM - StreetInsider
Form PRE 14A LISATA THERAPEUTICS, For: Nov 09
October 7, 2026 5:17 PM - SEC Filing
Marea Therapeutics doses first patient in phase 2 acromegaly trial
October 5, 2026 8:00 AM - StreetInsider
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acr
October 5, 2026 8:00 AM - StreetInsider
Form D LISATA THERAPEUTICS,
October 2, 2026 4:24 PM - SEC Filing
Form 3 LISATA THERAPEUTICS, For: Sep 17 Filed by: LOVE TED W
September 28, 2026 9:31 PM - SEC Filing
Form 3 LISATA THERAPEUTICS, For: Sep 17 Filed by: Lehrer-Graiwer Joshua
September 28, 2026 9:30 PM - SEC Filing
Marea Therapeutics to present MAR001 trial data at AHA 2026
September 24, 2026 8:04 AM - StreetInsider
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026
September 24, 2026 8:00 AM - Globe NewsWire
Form 8-K LISATA THERAPEUTICS, For: Sep 17
September 17, 2026 9:28 AM - SEC Filing
Lisata acquires Marea Therapeutics, raises $225M in private placement
September 17, 2026 9:27 AM - StreetInsider
Lisata Therapeutics Announces Acquisition of Marea Therapeutics and $225 Million Concurrent Private Placement
September 17, 2026 9:26 AM - Globe NewsWire
Form SCHEDULE 13G LISATA THERAPEUTICS, Filed by: Branham Justin Earl
August 26, 2026 1:03 PM - SEC Filing
Form 10-Q LISATA THERAPEUTICS, For: Jun 30
August 6, 2026 4:04 PM - SEC Filing
Lisata sues Kuva Labs after merger collapse, cuts 72% of staff
August 4, 2026 7:03 AM - StreetInsider
Lisata Therapeutics Provides Update Following Termination of Merger Agreement
August 4, 2026 7:00 AM - StreetInsider
Form 8-K LISATA THERAPEUTICS, For: Aug 03
August 4, 2026 6:05 AM - SEC Filing
Form SC TO-T/A LISATA THERAPEUTICS, Filed by: Kuva Labs, Inc.
July 28, 2026 4:37 PM - SEC Filing
Brookline Capital Markets Downgrades Lisata Therapeutics, Inc (LSTA) to Hold
July 27, 2026 9:53 AM - StreetInsider
Form 8-K LISATA THERAPEUTICS, For: Jul 24
July 24, 2026 12:16 PM - SEC Filing
Full Article List
